Three of the four major inhaler manufacturers have announced plans to cap patient copays for all ... Administration’s ...
Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs for its inhalers at $35 a month ... review patents listed in the FDA’s Orange Book — a registry of drugs approved ...